The Expression Of Prostatic Acid Phosphatase In Prostate Cancer Bone Metastases
One of the major causes of prostate cancer morbidity and mortality is bone metastases. Currently, when it comes to treating prostate cancer metastases we are very limited in effective therapies that actually prolong survival. Kirschenbaum [...]
Osteonecrosis Of The Jaw While Taking Zometa & Xgeva
The use of denosumab (Xgeva) as an alternative to the more commonly prescribed zoledronic acid (Zometa) to slow down the development of bone metastases in men with advanced prostate cancer is becoming more common. The [...]
Hormone Therapy (ADT) Does Not Increase The Risk Of Cardiac Threats in Prostate Cancer
Again, prostate cancer confusion continues to reign. A recent study reported at the ASTRO (American Society for Radiation Oncology) conference claims that the addition of androgen deprivation therapy (ADT) in men with clinically localized prostate [...]
A Hallmark Moment For Private Medical Insurers – The Impact of the Affordable Care Act
We have just reached a red letter moment in the area of medical insurance. The provision of the Affordable Care Act that requires medical insurers to spend 80% of the consumers’ premium dollars they collect—85% [...]
Hormonal Therapy (ADT) Is Associated With An Increase of Thrombotic Events
A recent article in the journal Cancer reported that there is an association for men being treated for prostate cancer with androgen deprivation therapy (ADT) and a risk of developing blood clots. The article, written [...]
Prostate Cancer and the Role of Genes As Prognosticators
We know that both a positive family history and racial background are among the strongest epidemiological risk factors for prostate cancer. It is also recognized that the role of candidate genetic markers to prostate cancer [...]